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Abstract
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS)
with  a  focus  on  inflammation,  demyelination,  and  damage  to  axons  leading  to
neurological deficits. MS pathology is associated with excessive reactive oxygen species
(ROS) and generation of reactive nitrogen species (RNS), causing oxidative/nitrosa‐
tive stress.  Deregulation of glutathione homeostasis and alterations in glutathione‐
dependent  enzymes  are  implicated  in  MS.  Reactive  oxygen  species  enhance  both
monocyte adhesion and migration across brain endothelial cells. In addition, ROS can
activate the expression of the nuclear transcription factor‐kappa, which upregulates the
expression of many genes involved in MS, such as tumor necrosis factor‐α and nitric
oxide synthase, among others, leading to mitochondrial dysfunction and energy deficits
that  result  in  mitochondrial  and  cellular  calcium overload.  Loss  of  mitochondrial
membrane potential can increase the release of cytochrome c, one pathway that leads
to neuronal apoptosis. Clinical studies suggest that omega‐3 long‐chain polyunsaturat‐
ed fatty acids (PUFAs) including eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) have anti‐inflammatory, antioxidant, and neuroprotective effects in MS and
animal  models  of  MS.  Here,  we  review  the  relationship  of  oxidative  stress,  the
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glutathione  redox  system,  the  ATPase  system,  and  membrane  fluidity  with  the
development  of  MS.  In  addition,  we describe  the  main findings  of  a  clinical  trial
conducted with relapsing‐remitting MS patients who received a diet supplemented with
4 g/day of fish oil or olive oil. The effects of PUFAs supplementation on the parame‐
ters indicated above are analyzed in this work.
Keywords: multiple sclerosis, oxidative stress, mitochondria, membrane fluidity, AT‐
Pase
1. Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous
system (CNS) with partially known etiology. It is the most common cause of neurological
disability in young adults. Nutrition is commonly accepted as one of the possible environ‐
mental factors involved in the pathogenesis of MS. Omega‐3 polyunsaturated fatty acids
(PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are fatty acids
that possess several carbon–carbon double bonds. A diet supplemented with PUFAs has
clinical and biochemical effects in patients with autoimmune diseases such as MS. Eicosapen‐
taenoic acid and DHA are found in high proportions in fish oil, and these molecules may have
anti‐inflammatory, antithrombotic, antioxidant, immunomodulatory functions, and neuro‐
protective effects on the synaptogenesis and biogenesis of the neuronal membrane. Oxidative
stress (OS) that is characterized by excessive production of reactive oxygen species and a
reduction in antioxidant defense mechanisms have been implicated in the pathogenesis of MS.
In consequence, a reduction in this phenomenon could be beneficial for MS patients [1]. In this
work, we describe the relationship of several oxidative stress markers (glutathione redox
system, mitochondrial ATPase activity, and membrane fluidity) with the development of MS.
Furthermore, we describe the main findings of a clinical trial conducted with relapsing–
remitting MS patients who received a diet supplemented with 4 g/day of fish oil or olive oil.
Pathologically, MS is characterized by perivenous infiltration of lymphocytes and macro‐
phages in the brain parenchyma. There are four clinical manifestations of MS: relapsing–
remitting, primary progressive, secondary progressive, and progressive‐relapsing. The MS
lesions are typically scattered, and the clinical picture can vary from a benign self‐limiting
disorder to severe and highly disabling disease. MS is a multifactorial disease involving
genetic, immunological, and environmental factors that trigger the autoimmune process
leading to the pathological changes of the disease. In this regard, it has been proposed that a
viral infection in which self‐antigens that generate molecular mimicry with myelin proteins
cause a loss of tolerance against it, which results in the destruction of myelin mediated by
activated T lymphocytes in white matter of the brain and sometimes extending into the gray
matter, resulting in defects in the conduction of nerve impulses that leads to symptoms,
depending on the affected site of the brain or spinal cord [1] (Figure 1).
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According to the areas of myelin destruction, sensory or motor symptoms are affected (balance
or vision disorders). The symptoms can change between an “outbreak” or relapse (emergence
of new neurological symptoms or worsening of previous ones) and remission. Demyelinating
lesions or “plaques” of different sizes and locations are spread throughout the CNS, and the
onset of symptoms and response to treatment is unique to each patient [2].
Figure 1. Immune‐mediated destruction of myelin components in multiple sclerosis. Pathway Builder Online Tool was
used to draw the figure [27].
2. Oxidative stress and multiple sclerosis
OS is a cellular state where the homeostasis of redox reactions is altered when the production
of reactive oxygen (ROS) and reactive nitrogen species (RNS) exceed their elimination. These
reactive species are generated, among other causes, by oxidative metabolism. Neurons of the
CNS are very active in oxidative metabolism, as they are constantly exposed to low‐to‐
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moderate levels of ROS, and these species are removed by antioxidants (melatonin, vitamin
D, vitamin E, glutathione) and antioxidant enzymes (superoxide dismutase, catalase, gluta‐
thione peroxidase, etc.). In chronic inflammatory diseases, such as MS, antioxidant defenses
are overcome, which leads to oxidative stress [3].
Collectively, the ROS are reactive species derived from oxygen that include the superoxide
anion (O-), hydrogen peroxide (H2O2), and the hydroxyl radical (•OH). The RNS are reactive
species derived from nitrogen and include nitric oxide (NO∙) and peroxynitrite (ONOO-). The
ROS and RNS are extremely unstable and reactive because they have an unpaired electron in
their outer orbital. They take electrons from proteins, lipids, carbohydrates, and nucleic acids,
causing damage to biological membranes, genetic material, and other macromolecules. The
CNS is particularly vulnerable to oxidative damage since it has a very active mitochondrial
metabolism, which leads to high levels of intracellular superoxide anions. Moreover, oligo‐
dendrocytes have low levels of antioxidant enzymes and a high concentration of iron.
Unsaturated fatty acids are the most vulnerable to free radicals, and because myelin has a high
lipid‐to‐protein ratio, it is a preferred target of ROS [4]. The ROS are generated by a number
of cellular oxidative and metabolic processes including activity of the enzymes of the mito‐
chondrial respiratory chain, xanthine oxidase, NADPH oxidase, monoamine oxidases, and
metabolism of arachidonic acid (AA) mediated by the activity of lipoxygenases (LOX), and
ROS are produced primarily by leakage of electrons in the mitochondrial respiratory chain [3].
Figure 2. Oxidative stress levels are directly related to the progression of MS. Pathway Builder Online Tool was used
to draw the figure [27].
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Numerous studies in MS patients have shown an increase in the production of OS markers
(such as cholesteryl ester hydroperoxides) and lower levels of uric acid (a ONOO- scavenger).
These changes are accompanied by significant deficiencies in antioxidant enzymes compared
to healthy subjects. The increase in ROS coupled with decreased antioxidant capacity is not
enough to entirely explain the pathogenesis of MS [4, 5]. Other reports suggest that the loss of
myelin nerve sheath is possible because the immune system participates in combination with
defects in the mitochondria, and these defects cause the generation of ROS and RNS. Macro‐
phages and monocytes release mediators of OS that degrade the unsaturated fatty acids. The
ROS have also been implicated as a mediator of demyelination of axonal damage in MS and
experimental autoimmune encephalomyelitis (EAE) [6]. It is important to mention that in
assessing platelets in MS patients, increased activity of free radicals with decreased levels of
important antioxidants such as glutathione and alpha‐tocopherol has been reported [7]
(Figure 2).
Figure 3. Damage to axons. Pathway Builder Online Tool was used to draw the figure [27].
The molecular mechanisms proposed to explain how ROS could specifically mediate brain
damage are the following: (1) The lower levels of antioxidants can promote increased activity
of lipoxygenase in CNS stimulating leukotriene production, thereby increasing the immu‐
noinflammatory processes in the cerebral cortex; (2) the damage to myelin can be caused by
activation of T cells that may be activated for the presence of free radicals produced by the
synthesis route of AA. Then appear the markers of OS associated with reduced activity of
superoxide dismutase and the increase in glutamine, followed by increases of ∙OH and the
production of peroxides which ultimately has a negative impact on myelin. After that, the
evident changes in mitochondrial activity and finally changes in membrane fluidity (particu‐
larly, mitochondrial membranes) appear [8].
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Figure 4. Effect of nitric oxide in inflammation. Pathway Builder Online Tool was used to draw the figure [27].
Paraclinical studies have shown an increased metabolism of the RNS in serum, lymphocytes,
and cerebrospinal fluid of MS patients, which correlate to pathology studies. ONOO- is also
closely associated with acute inflammatory lesions [9]. Damage to axons is mediated by the
following: (1) failure in mitochondrial energy metabolism due to inhibition of the respiratory
chain by nitric oxide, which in turn causes a decrease in Na+/K+ ATPase activity and alters Na
+‐dependent glutamate transporters, (2) over‐expression of glutamate receptors, (3) oligoden‐
droglial excitotoxicity, (4) massive influx of extracellular Ca++, (5) activation of proteases, and
(6) impaired axonal transport. These mechanisms produce glutamate excitotoxicity and
increased generation of nitric oxide leading to nitrosative stress. Nitric oxide is a highly toxic
element that by itself blocks nerve conduction, especially in demyelinated axons, and stimu‐
lates apoptosis. When nitric oxide is combined with the superoxide anion, it generates a potent
free radical, the pro‐oxidant peroxynitrite. Glutamate in turn causes neurodegeneration
through the AMPA and NMDA receptors in oligodendrocytes and astrocytes (Figure 3). It is
possible to explain the role of mediators using an experimental model of autoimmune
encephalitis: Protection against the experimental disease occurs after administration of a
glutamate antagonist [10].
Under physiologic conditions, nitric oxide is produced from L‐arginine by constitutive nitric
oxide synthase (cNOS) and participates in a variety of important biological functions such as
immunoregulation of inflammatory reactions, the downregulation of tumor necrosis factor
(TNF)‐α production, MHC II expression in macrophages, induction of apoptosis in CD4 cells,
physiological regulation of the mitochondrial respiratory chain, inhibition of antigen presen‐
tation, and leukocyte adhesion and migration. However, during inflammatory reactions,
exposure of macrophages to interferon (IFN)‐γ and TNF‐α results in the activation of the
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inducible isoenzyme of NOS (iNOS), which increases up to 10 times the levels of nitric oxide.
Nitric oxide facilitates the formation of peroxynitrite radicals. Only cells capable of generating
a high flow of NO• have the potential for causing nitrosative stress. The role of nitric oxide in
MS is therefore complex, and in fact, peroxynitrite is definitely more toxic than nitric oxide [9]
(Figure 4).
3. Reactive oxygen species, cytokines, and axonal damage in multiple
sclerosis
Mechanisms of axonal damage are the consequence of the presence of TNF‐α, matrix metal‐
loproteinases (MMPs), ROS, antibodies, increased glutamate, and aspartate, and these
molecules cause excitotoxicity in MS patients. Glutamate is increased in MS patients (active
lesions) especially in white matter of normal appearance. Mature oligodendrocytes and
astrocytes are highly sensitive to glutamate due to the expression of AMPA and NMDA
receptors [9]. The myelin sheath can be damaged by cytokines, autoantibodies, ROS, proteo‐
lytic enzymes, and phagocytosis. Increased ROS by activated microglia (specialized macro‐
phages of the CNS) during the immune response gives a state of increased lipid peroxidation,
and the oligodendrocyte cell is the cell most susceptible to damage by ROS. Myelin degradation
may be the result of lipid peroxidation mediated by peroxides, but the role of these specific
toxic factors in the pathogenesis of MS remains partially elusive [9].
4. Glutathione system and multiple sclerosis
In a recent study, the oxidation of DNA in the nucleus of oligodendrocytes and oxidation of
lipids in the myelin of oligodendrocytes and axons were observed. This oxidation was
associated with the active process of demyelination and neurodegeneration. Active lesions in
relapsing‐remitting MS (RRMS) and progressive course patients were associated with
inflammation, lipid peroxidation, and DNA oxidation [11]. Similarly, Ortiz et al. [12] observed
an increase in serum lipid peroxides and nitrite/nitrate levels and the activity of glutathione
peroxidase in patients with RRMS compared to healthy individuals.
Reduced ubiquinone and vitamin E levels, and reduced activity of the enzyme glutathione
peroxidase in lymphocytes and granulocytes were reported (with a decrease in 51 and 78%,
respectively), as well as a decrease in glutathione reductase activity in granulocytes (27%) and
lymphocytes (8%) [13]. In contrast, in 2012, Tasset et al. [14] found an increase in activity of the
glutathione reductase in patients with RRMS when compared to control subjects (1.3 ± 0.9 vs
0.3 ± 0.19, P < 0.01), and an increased ratio of reduced glutathione to oxidized glutathione
(GSH/GSSG) in these patients (28.2 ± 39.6 vs 4.0 ± 2.9, P < 0.01). Similarly, an increase was found
in the levels of oxidized glutathione and also increased concentrations of isoprostanes and
malondialdehyde (MDA) in patients with MS [15, 16].
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4.1. Glutathione deficiency and multiple sclerosis
There are several reports in the literature that relate the decrease or alteration of glutathione
(GSH) metabolism with several neurodegenerative diseases. Biochemical analysis of postmor‐
tem brains has provided evidence for the generation of oxidative stress during the course of
the disease since the total GSH content is reduced by 40–50% compared to controls. Also in
several brain regions, we have found increased levels of lipid peroxidation [17]. The ratio GSH/
GSSG (usually 10:1) is considered consistent with the concept of oxidative stress as an
important part in the pathogenesis of MS. Moreover, low concentrations of GSH appear to be
an important indicator of oxidative stress during the progression of MS. Although the decrease
in GSH alone is not responsible for the degeneration of glial cells and neurons, reduced GSH
could increase the susceptibility to other stressful factors and contribute to neuronal damage
at glia and neuron cells. Glutathione has been reported to protect mitochondrial complex I
activity against nitrosative stress, as S‐nitrosoglutathione is formed. When this complex
increases its content of nitrotyrosine and nitrosothiol groups in response to nitrosative stress,
its activity is inhibited and therefore ATP production is diminished, which causes neuronal
degeneration [10]. The role of glial cells in generating ROS in MS and the selective vulnerability
of neurons is due to activated glial cells surrounding these neurons, as these glial cells are also
directly involved in GSH levels. The engagement of the glutathione system in astroglial cells
contributes to the reduction in its antioxidant defenses and so poor glial defense could
contribute to existing neuronal damage (Figure 5) [10]. Furthermore, the specific activities of
some enzymes that metabolize GSH are high, as in the case of glutathione peroxidase,
glutathione reductase, and glutathione S‐transferase. Other products of OS are also elevated,
as in the case of 4‐hydroxynonenal (4‐HNE, a product of lipid peroxidation of polyunsaturated
omega‐6 fatty acids) [17].
Figure 5. Genetic defect in glutathione synthesis and neurodegenerative diseases. Pathway Builder Online Tool was
used to draw the figure [27].
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A new proposal is that a genetic defect of glutathione synthesis may be the initial event in the
failure of the antioxidant defenses. In neurodegenerative diseases, a decreased GSH level is
accompanied by dysfunction of the mitochondrial complex I and complex IV and promotes
oxidative stress [18]. We found a significant decrease in GSH levels in the cerebrospinal fluid
of patients with this disease, and, in addition, proton magnetic resonance studies have shown
a 50% decrease in GSH levels in the frontal cortex of patients with MS (Figure 5).
5. Mitochondria
Mitochondria are granular and filamentous organelles found in the cytoplasm of all eukaryotic
cells and are the main site of adenosine triphosphate (ATP) synthesis by the processes of
oxidative phosphorylation. These organelles vary in size and shape depending on the source
and metabolic status, but are often ellipsoids of about 5 microns in diameter and 1 micron long.
A typical eukaryotic cell contains more than 2,000 mitochondria, which takes up about one‐
fifth of the cell volume, an amount that is needed to meet the energy demands of the cell. Its
main function is the mitochondrial respiration process in which the reducing power produced
in the oxidation reactions enters the electron transport chain and energy is captured in the form
of adenosine triphosphate (ATP). Mammalian tissues containing more mitochondria are the
heart and brain [19]. The mitochondrion is formed by two membranes: the outer membrane
and the inner membrane, which is highly folded, and the inner matrix is gel (approximately
50% water) [20].
The outer mitochondrial membrane contains porin, a pore‐forming protein that allows
diffusion of up to 10 kD molecules). The inner membrane contains approximately 75% protein
and 25% lipids by weight, and it is much richer in outer membrane proteins. The inner
membrane is permeable only to carbon dioxide (CO2), oxygen (O2), and water (H2O). The
passage of metabolites such as ATP, adenosine diphosphate (ADP), pyruvate, calcium ions
(Ca2+), and phosphate (PO4) is regulated by controlling the transport proteins. This controlled
permeability allows the generation of ionic gradients and results in the compartmentalization
of metabolic functions between the cytoplasm and mitochondria. The inner membrane
components of the respiratory chain are responsible for the synthesis of ATP (ATP synthase
FoF1) [22], where the enzyme complex is housed. The inner membrane is arranged in ridges,
giving it a large surface area: A single mitochondrion may have more than 10,000 sets of
electron transfer systems (respiratory chain) and ATP synthase molecules distributed through‐
out the membrane's internal surface [21]. The inner membrane is, from the functional point of
view, the most important because it contains the components of the respiratory chain and
proteins necessary for the synthesis of ATP [21]. The mitochondrial matrix is the space
delimited by the inner membrane and contains the pyruvate dehydrogenase complex and the
enzymes of the tricarboxylic acid cycle (TCA), the fatty acid oxidation, and the oxidation of
amino acids [21] (Figure 6).
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Figure 6. Main mitochondrial metabolic pathways. An important component of metabolic regulation is specialization.
Mitochondria have a role in biosynthesis, catabolism, and energy metabolism, including citric acid cycle, oxidative
phosphorylation, and fatty acid breakdown pathways.
The chemical energy required for cellular activities such as biosynthesis, transportation of ions
and molecules, and mechanical work comes from ATP. Mitochondria generate more than 90%
of the energy needed for the proper functioning of tissues that are highly dependent on aerobic
metabolism, such as the brain and heart. This subcellular organelle provides the energy
necessary for the production of ATP [22]. Depending on cell type and metabolic state, mito‐
chondria consume approximately 90–95% of the oxygen consumed by the cell. The energy of
this process, in which electrons are transferred from the substrates of the TCA to oxygen, is
coupled to vectorial transport of H+ from the mitochondrial matrix space [22].
The electron carriers, reduced nicotinamide dinucleotide adenine (NADH) and reduced flavin
dinucleotide adenine (FADH2), originating mainly in the TCA cycle, confer the energy that
electrons carry. This energy is released gradually along the respiratory chain in the mitochon‐
drial inner membrane. In this membrane, an exchange of electrons between the enzymatic
complexes is given by NADH or FADH2 [20].
The complexes are as follows: I (NADH‐ubiquinone reductase), II (succinate‐ubiquinone
reductase), III (ubiquinol‐cytochrome c reductase), IV (cytochrome oxidase), and V (ATP
synthase complex FoF1) [20]. Electron transport is carried out by complexes I, III, and IV that
produce a flow of electrons accompanied by a movement of protons from the mitochondrial
matrix to the intermembrane space (space between the inner and outer mitochondrial mem‐
brane). This produces a difference in proton concentration and a difference in charge across
the membrane [20]. The proton‐motive force generated thereby drives protons through the
F0F1‐ATP synthase, allowing condensation of a phosphate group to ADP, with the formation
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of ATP [23]. Meanwhile, the complex F0F1‐ATP synthase is an enzyme located in the inner
membrane of the mitochondria, responsible for ATP synthesis from ADP and a phosphate
group (Pi), and the energy is supplied by a flow of protons (H+). The difference between the
terms ATPase and ATP synthase is that the enzyme has a dual function: It breaks down ATP
to ADP and Pi (activated ATPase), and it also allows for catalyzing Pi binding of ADP using
the proton gradient for ATP synthesis (ATP synthase activity). As complex V has both
functions, we can name it indiscriminately when speaking in general terms of the enzyme [23].
This enzyme is constituted by two components: a soluble portion (F1), located in aqueous
medium, and another portion (Fo), which is lipid soluble. The Fo part is inserted into the lipid
bilayer and is sensitive to the antibiotic oligomycin (Figure 7).
Figure 7. ATP synthase complex structure. The ATP synthase complex plays a central role in energy transduction in
living cells that uses energy released by the movement of protons down a transmembrane electrochemical gradient to
drive the synthesis of ATP. This enzyme is located in the inner membrane of mitochondria and is constituted by two
parts: a soluble portion (F1) in aqueous medium and another portion (Fo) lipid soluble. The Fo part is inserted into the
lipid bilayer.
On the other hand, pathophysiological features exhibited the association between mitochon‐
drial dysfunction, decreased activity of complex I and complex IV of the electron transport
chain, and the glutathione system in MS [23].
6. Mitochondria and multiple sclerosis
In acute phases of the disease, axonal degeneration correlates with the severity of inflamma‐
tion. This type of injury has been used in an experimental model of autoimmune encephalo‐
myelitis (EAE), where acute mitochondrial damage within axons is detected and later suffers
from focal damage as a preliminary pathological step of axonal damage [15].
Complex IV of the mitochondrial electron transport chain has a binding site for O2 (The final
acceptor in the respiratory chain) and catalyzes the reduction in O2 to H2O. Interestingly, nitric
oxide inhibits mitochondrial respiration by reacting with either the reduced or the oxidized
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binuclear site of cytochrome c oxidase, leading to ATP depletion. In cases of excessive nitric
oxide production, complete inhibition of cytochrome c oxidase has been shown to contribute
to pathology.
Figure 8. Association of mitochondrial electron transport chain with oxidative stress. The mitochondrial electron trans‐
port chain (ETC), which is composed of four multiprotein complexes named complex I–IV, has been recognized as one
of the major cellular generators of free radicals. Leakage of electrons directly from the intermediate electron carriers
generates reactive oxygen species that leads to membrane lipid peroxidation, mitochondrial DNA damage, and the re‐
lease of cytochrome C to the cytosol triggering apoptosis.
At the same time, interrupting the electron transport chain by binding of NO to complex IV
increases electron release, thus facilitating the formation of reactive oxygen species, firstly
superoxide anion and subsequently H2O2 and OH..Peroxynitrite has a direct effect on mito‐
chondria leading to lipid peroxidation of membrane lipids and thus damaging the complexes
of the respiratory chain and mitochondrial DNA. Opening of permeability transition pores
and release of cytochrome C from mitochondria initiate apoptosis (Figure 8).
At the stage of acute inflammation, a set of mechanisms that alter mitochondrial function is
produced. The energy deficit causes structural and functional damage to macromolecules by
increased ROS that ultimately leads to severe axonal damage. In these events, the mitochondria
has an important role; therefore, if we know what the mechanisms involved in glial and
neuronal alterations are, we must be able to identify the elements that can be used as effector
elements and design drugs to control and reduced harm during the stage of relapse [14].
Many demyelinated axons survive during a relapse, and these can become chronically
demyelinated axons, in which case axonal mitochondria develop compensatory mechanisms
to cope with the lack of myelin. There are reports in which inactive lesions from chronic
demyelinated axons of patients with MS are observed. In such reports, they have found an
increase in the activity of mitochondrial complex IV and increased synphilin anchoring protein
[19]. However, axons progressively degenerate in chronic lesions of MS patients. In the absence
of myelin, redistribution of Na+ occurs to maintain the transmission of nerve impulses that
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increases energy demand, and this produces a situation of “virtual hypoxia.” At the end, the
demand exceeds the capacity of axonal mitochondria to produce enough ATP, which causes
an increase in the concentration of Ca2+ in the axon. Ca2+ pumping and extended levels of
intramitochondrial calcium leads to opening pores, rupture of the outer mitochondrial
membrane, and release of cytochrome C, finally leading to apoptosis (Figure 8).
One of the questions we have not answered is: Why are mitochondria helpless and over‐
whelmed by the energy demand and how does this happen? Are the axons unable to maintain
stable mitochondrial activity in demyelination?. This reflects the inability of the cell to carry
and generate mitochondria. Dutta et al. [23] have shown decreased gene expression of 26
nuclear‐encoded subunits of the oxidative phosphorylation chain in non‐demyelinated motor
cortex from MS patients, which coincided with a significant reduction in activity of NADH
dehydrogenase and ubiquinol‐cytochrome c reductase . In the progressive phase of MS, it is
postulated that chronically demyelinated axons are unable to maintain mitochondrial func‐
tion, and thus, a deficit of ATP synthesis coupled with oxidative stress results in irreversible
axonal damage.
7. Effect of fish oil (Omega3) and olive oil on membrane fluidity, ATPase
activity in relapsing‐remitting multiple sclerosis.
The mechanism of action for omega‐3 PUFAs is suggested to be attributed to immunomodu‐
lation and antioxidant action [24]. For instance, omega‐3 PUFAs decrease the production of
inflammatory mediators (eicosanoids, cytokines, and ROS) and the expression of adhesion
molecules. They both act directly by replacing AA as an eicosanoid substrate and inhibiting
AA metabolism and indirectly by altering the expression of inflammatory genes through
effects on transcription factor activation. Omega‐3 PUFAs also give rise to anti‐inflammatory
mediators (resolvins and protectins) [25]. Effects of resolvins and protectins include reducing
neutrophil trafficking, cytokine, and ROS regulation and lowering the magnitude of the
inflammatory response [26].
Previously, we developed a twelve‐month randomized double‐blind controlled clinical trial
in 50 patients with relapsing‐remitting MS. Patients received an oral dose of 4 g/day of fish oil
(containing a total of 800 mg of EPA and 1600 mg of DHA) or olive oil. Fasting blood samples
were collected at baseline and after 6 and 12 months of the trial, in order to evaluate the effect
of consumption of omega‐3 PUFAs on some markers of oxidative stress at the peripheral level.
The initial findings of this work were the decrease in serum levels of TNFα, IL‐1β, IL‐6, and
nitric oxide metabolites compared with the placebo group [27].
On the other hand, after 12 months of intervention, supplementation with omega‐3 PUFAs
significantly enhanced the quantities of serum omega‐3 highly unsaturated fatty acids
compared with baseline values. Additionally, the levels of medium‐chain monounsaturated
fatty acids were significantly decreased. The olive oil supplementation induced minor
decreases in EPA and DHA levels after 12 months of intervention. There were significant
increases in both EPA and DHA in the group given fish oil supplementation compared to the
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control group receiving olive oil. These increases were associated with a concomitant decrease
in AA. Consequently, the omega‐3 fatty acid index in the fish oil group increased significantly,
and the ratios of n‐6/n‐3 and AA/EPA were decreased [28].
No differences in glutathione reductase activity and content of reduced glutathione, oxidized
glutathione, and oxidized/reduced glutathione ratio were seen after 12 months of supplemen‐
tation with omega‐3 PUFAs. However, a trend in favor of omega‐3 PUFAs supplementation
was observed in GSSG levels and glutathione reductase activity at 12 months of intervention
between the study groups [28].
A steady decrease in mitochondrial ATPase activity in platelets was observed in the groups
given omega‐3 fatty acid and the control group receiving olive oil. Membrane fluidity of
platelets was significantly reduced in MS patients. Interestingly, a significant increase in
platelet membrane fluidity was observed in the groups receiving omega‐3 fatty acid and the
control group receiving olive oil. As well, the fluidity of erythrocyte membranes was un‐
changed for both treatments (Unpublished results).
Epidemiological and experimental studies suggest an increased incidence of MS in popula‐
tions with a high intake of saturated fats mainly from animal sources. Therefore, by consuming
a diet high in fatty acids, without an appropriate number of unsaturates, a shift is produced
in the integrity and functionality of the membrane [29]. An optimal balance in the consumption
of fatty acids includes 35% polyunsaturated fatty acids and 65% saturated fatty acids, and the
appropriate proportion of PUFA to maintain membrane balance is 50% omega‐3 with 50%
omega‐6. The above ratio was a factor that inactivated the CD4 autoreactive cells in the CNS,
a phenomenon that prevents the production of proinflammatory cytokines and free radicals
[30].
Membrane fluidity depends on the temperature, the ratio of saturated/PUFA fatty acids, the
presence of “lipid rafts,” and the proportion of cholesterol present at the membrane [31].
Previous studies in patients with rheumatoid arthritis had increased cell membrane rigidity
compared to membranes from those receiving immunomodulatory treatment. Our results
showed diminished platelet membrane fluidity in MS patients and that proper membrane
fluidity is restored with treatment of omega3 PUFAs. The increase in platelet membrane
fluidity is directly related to the incorporation of PUFA‘s. Furthermore, the increase in
membrane fluidity is accompanied with a significant decrease in mitochondrial ATPase
activity. This ensures that the activity of ATP synthesis in mitochondria remains elevated.
8. Conclusions
The inflammatory process seen in MS is due to an excess production of pro‐inflammatory
cytokines, which leads to increased secretion of ROS. Oxidative stress plays a preponderant,
key role in the pathogenesis of MS. Reactive oxygen species generated by macrophages have
been implicated as mediators of demyelination and axonal damage in EAE and MS. The main
findings of a clinical trial conducted with relapsing‐remitting MS patients who received a diet
supplemented with 4 g/day of fish oil or olive oil are the following:
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1. Fish oil supplementation resulted in a high increase in proportions of EPA and DHA,
leading to a decrease in AA concentrations as well as the AA/EPA ratio. These changes in
fatty acids are indicative of a reduction in the production of inflammatory eicosanoids
from AA and an increase in anti‐inflammatory mediators such as resolvins and protectins.
2. No differences in glutathione reductase activity, content of reduced and oxidized
glutathione, and GSH/GSSG ratio were seen after 12 months of supplementation. How‐
ever, fish oil supplementation resulted in a smaller increase in GR compared with the
control group. In addition, there was a significant change in glutathione reductase activity
within subjects in the fish oil group after 6 months of treatment, while no significant
differences within subjects were observed in the control group, suggesting a possible effect
of fish oil on antioxidant defense mechanisms of the cell. Although glutathione reductase
activity was not significantly different between the groups, fish oil supplementation
resulted in a smaller increase in GR compared with the control group, suggesting a
possible antioxidant effect of fish oil supplementation.
3. Membrane fluidity of platelets was significantly reduced in MS patients. That membrane
property steadily increased in the groups given omega‐3 fatty acid and the control group
receiving olive oil. The increases in membrane fluidity of platelets were associated with
a decrease in mitochondrial ATPase. As well, the fluidity of erythrocyte membranes was
unchanged for both treatments (unpublished results).
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